Browse > Article
http://dx.doi.org/10.4070/kcj.2011.41.9.546

Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction  

Choi, Woong-Gil (Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital)
Oh, Se-Won (Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital)
Kim, Young-Joong (Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital)
Lim, Jong-Gu (Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital)
Jo, Yoon-Sik (Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital)
Publication Information
Korean Circulation Journal / v.41, no.9, 2011 , pp. 546-548 More about this Journal
Abstract
Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibitor during PCIs is very low. We report the case of a 47-year-old man who presented with AMI and suffered an acute cerebral infarction after infusion of a GP IIb/IIIa inhibitor following primary PCI.
Keywords
Myocardial infarction; Acute stroke; Platelet glycoprotein GP IIb-IIIa complex;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Hess DC, D'Cruz IA, Adams RJ, Nichols FT 3rd. Coronary artery disease, myocardial infarction, and brain embolism. Neurol Clin 1993;11:399-417.
2 Komrad MS, Coffey CE, Coffey KS, McKinnis R, Massey EW, Califf RM. Myocardial infarction and stroke. Neurology 1984;34:1403-9.   DOI
3 Akkerhuis KM, Deckers JW, Lincoff AM, et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA 2001;286:78-82.   DOI   ScienceOn
4 Mooe T, Olofsson BO, Stegmayr B, Eriksson P. Ischemic stroke: impact of a recent myocardial infarction. Stroke 1999;30:997-1001.   DOI
5 Behar S, Tanne D, Abinader E, et al. Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance and short- and long-term mortality rates. Am J Med 1991;91:45-50.   DOI   ScienceOn
6 Torgano G, Zecca B, Monzani V, et al. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial. Cerebrovasc Dis 2010;29:275-81.   DOI   ScienceOn
7 Oh YJ, Park TH, Choi YJ, et al. Abciximab (ReoPro)-induced thrombocytopenia diagnosed through measurement of heparin-dependent antibody. Korean Circ J 2009;39:75-8.   DOI   ScienceOn
8 Frishman WH, Burns B, Atac B, Alturk N, Altajar B, Lerrick K. Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor. Am Heart J 1995;130:877-92.   DOI   ScienceOn
9 Chang GY. An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction. Eur J Neurol 2001;8:267-8.   DOI   ScienceOn